Amgen IncAmgen Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

The report of Amgen Inc was assembled by All Street Sevva using proprietary Cognitive Robots. Check the end of this webpage for potential risks for Amgen Inc based on industry, location and marketcap. This SDG score for Amgen Inc represents the company's reporting of the UN Sustainable Development Goals.

Amgen Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 6.9 and governance score of 8.0.

SDG Transparency Score for Amgen Inc 
Low
0 - 3
Medium
4 - 6

8.0

High Impact
7 - 10
Last Score Update: 2023-07-01
What drives the score for Amgen Inc 
8.0

Environmental

6.9

Social

8.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
36Repligen Corp
8.1
High
36Zealand Pharma A/S
8.1
High
55Amgen Inc
8.0
High
55Abbott India Ltd
8.0
High
55Amrutanjan Health Care Ltd
8.0
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Amgen Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Amgen Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Amgen Inc report the average age of the workforce?

LockedSign up for free to unlock

Does Amgen Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Amgen Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Amgen Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does Amgen Inc offer flexible work?

LockedSign up for free to unlock

Does Amgen Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Amgen Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Amgen Inc conduct supply chain audits?

LockedSign up for free to unlock

Does Amgen Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Amgen Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Amgen Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Amgen Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Amgen Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Amgen Inc disclose water use targets?

LockedSign up for free to unlock

Does Amgen Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Amgen Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does Amgen Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does Amgen Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Amgen Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Amgen Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does Amgen Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Amgen Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Amgen Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Amgen Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Amgen Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Amgen Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Amgen Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Amgen Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Amgen Inc disclose its waste policy?

LockedSign up for free to unlock

Does Amgen Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does Amgen Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Amgen Inc disclose energy use targets?

LockedSign up for free to unlock

Does Amgen Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Amgen Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Amgen Inc
These potential risks are based on the size, segment and geographies of the company.

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Sorry!

Failed to process!